CHENG Jinfeng,JIANG Wanli.Expression of GPSM1 in lung adenocarcinoma and its regulation and potential mechanism of glycolysis in lung adenocarcinoma cells[J].Medical Journal of Wuhan University,2025,46(06):729-737.
CHENG Jinfeng,JIANG Wanli.Expression of GPSM1 in lung adenocarcinoma and its regulation and potential mechanism of glycolysis in lung adenocarcinoma cells[J].Medical Journal of Wuhan University,2025,46(06):729-737.DOI: 10.14188/j.1671-8852.2024.0440.
Expression of GPSM1 in lung adenocarcinoma and its regulation and potential mechanism of glycolysis in lung adenocarcinoma cells
To investigate the expression of G‑protein signaling modulator 1 (GPSM1) in lung adenocarcinoma tissues and cells
and its impact on the invasion and migration of lung adenocarcinoma cells
along with potential mechanisms.
Methods
2
By analyzing the TCGA database through bioinformatics methods
we aimed to explore the differential expression of GPSM1 in lung adenocarcinoma tissues compared to normal lung tissues. Subsequently
we utilized Western Blot and qPCR techniques to measure the expression levels of GPSM1 in human normal bronchial epithelial cells (BEAS‑2B) and human lung adenocarcinoma cells (A549
H1299
and H460). Among these
H1299 and H460 cells with lower GPSM1 expression levels were selected for further experiments. Following this
we constructed a GPSM1 overexpression plasmid for transfection into lung adenocarcinoma cells and examined the impact of overexpressing or silencing GPSM1 on the invasive and migratory capabilities of lung adenocarcinoma cells using Transwell and wound healing assays
respectively. Additionally
we conducted an online analysis of co‑expressed genes of GPSM1 in lung adenocarcinoma and performed enrichment analysis using the LinkedOmics tool. Furthermore
through measuring the mRNA expression levels of key glycolysis enzymes and analyzing cellular energy metabolism
we elucidated the effect of GPSM1 on glycolysis in lung adenocarcinoma cells. Finally
we investigated the influence of the GPSM1/HIF‑1α axis on the invasive and migratory abilities of lung adenocarcinoma cells by using an activator of HIF‑1α.
Results
2
The gene GPSM1 exhibits low expression in both lung adenocarcinoma tissues and cells (both
P
<
0.01). Upon overexpression of GPSM1
the invasive and migratory abilities of lung adenocarcinoma cells significantly decrease. GPSM1 overexpression in lung adenocarcinoma is involved in multiple biological processes. Following GPSM1 overexpression
the glycolytic capacity of lung adenocarcinoma cells decreases
with glycolysis itself not affecting the expression levels of GPSM1. Overexpression of GPSM1 correlates with the downregulation of HIF‑1α expression in lung adenocarcinoma cells. Additionally
upon activation of HIF‑1α
the migratory and invasive capabilities of lung adenocarcinoma cells are restored.
Conclusion
2
The expression of GPSM1 is downregulated in both lung adenocarcinoma tissues and cells. This downregulation may promote invasion and migration of lung adenocarcinoma cells through activating the HIF‑1α/glycolysis pathway.
关键词
Keywords
references
SUNG H , FERLAY J , SIEGEL R L , et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2021 , 71 ( 3 ): 209 ‑ 249 .
ZHENG R S , ZHANG S W , SUN K X , et al . Cancer statistics in China, 2016 [J ] . Chin J Oncol , 2023 , 45 ( 3 ): 212 ‑ 220 .
TAN A C , TAN D S W . Targeted therapies for lung cancer patients with oncogenic driver molecular alterations [J ] . J Clin Oncol , 2022 , 40 ( 6 ): 611 ‑ 625 .
SANADA K , TSAI L H . G protein betagamma subunits and AGS3 control spindle orientation and asymmetric cell fate of cerebral cortical progenitors [J ] . Cell , 2005 , 122 ( 1 ): 119 ‑ 131 .
GROVES B , GONG Q , XU Z , et al . A specific role of AGS3 in the surface expression of plasma membrane proteins [J ] . Proc Natl Acad Sci USA , 2007 , 104 ( 46 ): 1 8103‑ 18108 .
VURAL A , MCQUISTON T J , BLUMER J B , et al . Normal autophagic activity in macrophages from mice lacking Gαi3,AGS3,or RGS19 [J ] . PLoS One , 2013 , 8 ( 11 ): e81886 .
YAN J , ZHANG Y M , YU H R , et al . GPSM1 impairs metabolic homeostasis by controlling a pro‑inflammatory pathway in macrophages [J ] . Nat Commun , 2022 , 13 ( 1 ): 7260 .
ADEKOYA T O , SMITH N , ALADENIYI T , et al . Activator of G protein signaling 3 modulates prostate tumor development and progression [J ] . Carcinogenesis , 2019 , 40 ( 12 ): 1504 ‑ 1513 .
CHEN Y , SONG Y L , WANG L . G‑protein signaling modulator 1 promotes colorectal cancer metastasis by PI3K/AKT/mTOR signaling and autophagy [J ] . Int J Biochem Cell Biol , 2023 , 157 : 106388 .
ZHANG Y , ZHOU B , SUN J J , et al . Knockdown of GPSM1 inhibits the proliferation and promotes the apoptosis of B‑cell acute lymphoblastic leukemia cells by suppressing the ADCY6‑RAPGEF3‑JNK signaling pathway [J ] . Pathol Oncol Res , 2021 , 27 : 643376 .
SHI H , REN H R , YANG X J , et al . Overexpression of activator of G‑protein signaling 3 decreases the proliferation of esophageal squamous cell carcinoma [J ] . Pathol Res Pract , 2015 , 211 ( 6 ): 449 ‑ 455 .
STINE Z E , SCHUG Z T , SALVINO J M , et al . Targeting cancer metabolism in the era of precision oncology [J ] . Nat Rev Drug Discov , 2022 , 21 ( 2 ): 141 ‑ 162 .
BAO X T , ZHANG J H , HUANG G M , et al . The crosstalk between HIFs and mitochondrial dysfunctions in cancer development [J ] . Cell Death Dis , 2021 , 12 ( 2 ): 215 .
LING S B , SHAN Q N , ZHAN Q F , et al . USP22 promotes hypoxia‑induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation [J ] . Gut , 2020 , 69 ( 7 ): 1322 ‑ 1334 .
ZHOU F , SUN J G , YE L Y , et al . Fibronectin promotes tumor angiogenesis and progression of non‑small‑cell lung cancer by elevating WISP3 expression via FAK/MAPK/HIF‑1α axis and activating Wnt signaling pathway [J ] . Exp Hematol Oncol , 2023 , 12 ( 1 ): 61 .
KERR E M , GAUDE E , TURRELL F K , et al . Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities [J ] . Nature , 2016 , 531 ( 7592 ): 110 ‑ 113 .
SINGH J P , QIAN K , LEE J S , et al . O‑GlcNAcase targets pyruvate kinase M2 to regulate tumor growth [J ] . Oncogene , 2020 , 39 ( 3 ): 560 ‑ 573 .
GÓMEZ V , EYKYN T R , MUSTAPHA R , et al . Breast cancer‑associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells [J ] . Sci Signal , 2020 , 13 ( 652 ): eaax4585 .
LIU J , ZHANG X M , CHEN K , et al . CCR7 chemokine receptor‑Inducible lnc‑Dpf3 restrains dendritic cell migration by inhibiting HIF‑1α‑Mediated glycolysis [J ] . Immunity , 2019 , 50 ( 3 ): 600 ‑ 615.e15 .
ZHENG F , CHEN J N , ZHANG X Q , et al . The HIF‑1α antisense long non‑coding RNA drives a positive feedback loop of HIF‑1α mediated transactivation and glycolysis [J ] . Nat Commun , 2021 , 12 ( 1 ): 1341 .
COWMAN S J , KOH M Y . Revisiting the HIF switch in the tumor and its immune microenvironment [J ] . Trends Cancer , 2022 , 8 ( 1 ): 28 ‑ 42 .
LI H X , LIANG J H , WANG J , et al . Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa‑miR‑6887‑3p [J ] . Cancer Commun (Lond) , 2021 , 41 ( 6 ): 472 ‑ 491 .
MA Q X , JIANG H F , MA L N , et al . The moonlighting function of glycolytic enzyme enolase‑1 promotes choline phospholipid metabolism and tumor cell proliferation [J ] . Proc Natl Acad Sci USA , 2023 , 120 ( 15 ): e2209435120 .
PARK J S , BURCKHARDT C J , LAZCANO R , et al . Mechanical regulation of glycolysis via cytoskeleton architecture [J ] . Nature , 2020 , 578 ( 7796 ): 621 ‑ 626 .